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Karin Humphries, PHD,*†‡ Christopher R. Thompson, MD, CM,*‡ Brad Munt, MD,*‡
Ajay Sinhal, MD,*‡ John G. Webb, MD*‡
Vancouver, British Columbia, Canada
O B J E C T I V E S This study was designed to investigate the usefulness and limitations of echocardi-
ography in optimizing the outcome of percutaneous aortic valve implantation.
B A C KG ROUND Percutaneous aortic valve implantation is an emerging technique that has the
potential to revolutionize the treatment of aortic valve disease. To date, however, the technique has
been limited by technical constraints. Precise positioning of the valve is essential to minimize the
potential for paravalvular regurgitation or device migration. Initial experience with device placement
utilized ﬂuoroscopic guidance only.
METHOD S Candidates for percutaneous aortic valve implantation were evaluated with transtho-
racic echocardiography (TTE) to assess aortic annular dimension and aortic valve hemodynamics. Fifty
consecutive patients were deemed suitable for percutaneous aortic valve implantation. Seventy-four
percent (37 of 50) of patients underwent transesophageal echocardiography (TEE) during the procedure.
R E S U L T S Eighty-six percent (43 of 50) of patients had successful implantation, of which 77% (33 of
43) had TEE. Transthoracic echocardiography was used to determine annular dimension and was useful
in guiding correct device sizing. Transesophageal echocardiography was able to successfully guide
device implantation in 97% (33 of 34) of patients in whom the native valve was crossed with the
percutaneous heart valve. Transesophageal echocardiography was used for the early detection of
paravalvular aortic regurgitation (AR) and complemented ﬂuoroscopy in the detection of complications.
Additional balloon dilatation of the percutaneous heart valve was performed in 12 patients because of
signiﬁcant paravalvular AR, with 7 showing improvement in AR grade. After the procedure, early
outcomes were evaluated using TTE. All patients in whom the device was successfully placed (43 of 50)
had improvement in their aortic stenosis. Paravalvular AR, although present in many patients, is usually
mild and has not emerged as a signiﬁcant problem.
CONC L U S I O N S Echocardiography has an important role in case selection, in guiding device
placement, and in detecting complications of percutaneous aortic valve implantation. (J Am Coll
Cardiol Img 2008;1:15–24) © 2008 by the American College of Cardiology Foundation
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‡University of British Columbia, Vancouver, British Columbia, Canada. Drs. Munt and Webb are consultants to Edwards
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16s the population ages, the timely and effective
treatment of calcific aortic stenosis will as-
sume increasing importance. Until recently
the only effective treatment for aortic
tenosis has been cardiac surgery and aortic valve
eplacement. Although percutaneous balloon aortic
alvuloplasty may be effective as a palliative proce-
ure, it often produces a suboptimal hemodynamic
nd clinical result and cannot be regarded as a
efinitive therapy (1,2).
See page 25
Building on the seminal work of Cribier et al. (3),
uccessful implantation of percutaneous heart valves
PHVs) with excellent clinical and hemodynamic
utcomes has been reported at our institution (4).
ransthoracic echocardiography (TTE) was routinely
sed to guide case selection and in the evaluation of
utcomes after PHV implantation. Transesophageal
chocardiography (TEE) has emerged as a vital ad-
junct to fluoroscopy in guiding PHV de-
ployment.
In this study we report on the role of
echocardiography in patient selection, de-
vice sizing, device placement, and evalua-
tion of outcome in patients undergoing
this new technique.
M E T H O D S
Patients. Fifty patients underwent PHV
implantation at our institution between
anuary 6, 2005 and May 29, 2006. The median age
as 81 years (range 62 to 94 years), and 30 of 50
atients (60%) were male. The procedure was ap-
roved for compassionate clinical use by the Ther-
peutic Products Directorate of Canada.
ercutaneous aortic valve implantation. The tech-
ique of transfemoral percutaneous aortic valve
mplantation and valve design has been described
lsewhere (4). In brief, the aortic valve was ap-
roached from a retrograde direction and the PHV
as deployed by rapid balloon inflation. If signifi-
ant paravalvular aortic regurgitation (AR) was
ound immediately after deployment, further bal-
oon inflations were performed.
reliminary TTE assessment. Transthoracic echocar-
iography was performed on all patients before the
rocedure. Images were recorded on a Philips Sonos
500 machine (Bothell, Washington) and the im-
ges were stored and archived in digital format.
alvearmonic imaging was used in all instances. Offlinemage analysis and measurement was performed
sing a Philips Xcelera digital archiving and report-
ng system. A standard transthoracic examination
as performed with special attention being paid to
he aortic annular dimension, severity of aortic steno-
is, and distribution and severity of valve calcification.
Measurement of the aortic annulus was performed
sing 2-dimensional imaging in a zoomed-up
arasternal long-axis view at the point of insertion
f the right and noncoronary aortic cusps into the
ortic annulus (Fig. 1A). Transesophageal echocar-
iography was used when poor imaging meant that
reliable estimate could not be made. Measure-
Figure 1. Aortic Annulus Dimension Assessed by Both TTE
and TEE
(A) Accurate transthoracic echocardiography (TTE) measurement
of the aortic annulus is essential to determine a patient’s suit-
ability for percutaneous heart valve (PHV) placement. Patients
are deemed unsuitable if the aortic annulus is either too large
(26 mm) or (rarely) too small. The TTE image shows a
zoomed-in parasternal long-axis view of the aortic annulus. The
aortic annulus measures 24 mm. (B) Before PHV deployment,
transesophageal echocardiography (TEE) is used to check the
aortic annulus measurement obtained by TTE. A difference of up
to 4 mm between the TTE and the TEE annulus measurements
can occur and may lead to a change in device size. Transesoph-
ageal echocardiography long-axis image of the patient as shownB B R E V I A T I O N S
N D A C R O N YM S
R aortic regurgitation
HV percutaneous heart v
EE transesophageal
chocardiogram/
chocardiography
TE transthoracic
chocardiogram/in panel A shows the aortic annulus measured at 28 mm.
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17ents of left ventricular size and function, wall
hickness, and pulmonary artery pressure were
oted. Valvular regurgitation was evaluated accord-
ng to published guidelines (5).
arly TTE assessment after device deployment. A
omplete TTE examination was performed on all
atients within 1 week of device implantation and
efore hospital discharge. Specifically, PHV hemo-
ynamics, post-deployment complications, and AR
rade were evaluated. Transaortic pressure gradient
nd aortic valve area were determined.
Aortic regurgitation was assessed using color
oppler, pressure half-time, vena contracta width,
nd flow reversal techniques. Aortic regurgitation was
raded as follows: zero or trace, mild, moderate, and
evere. Aortic regurgitation was classified as paraval-
ular, transvalvular, or both. The parasternal short-
xis view of the aortic valve was especially useful in this
egard. There are limited published data on grading
aravalvular regurgitation, and the assessment scheme
e have used is similar to that used by Kapur et al. (6).
rading was based primarily on the height of the
egurgitant jet in the parasternal long-axis view and
he circumferential extent of the jet in the short-axis
iew. When both valvular and paravalvular AR were
resent, AR was expressed as an overall grade. Left
nd right ventricular function, pulmonary artery pres-
ure, and grade of mitral and tricuspid regurgitation
ere determined.
EE imaging and guided valve deployment. Trans-
sophageal echocardiography was performed in
4% (37 of 50) of cases and is now performed
outinely. The TEE probe was introduced under
eneral anesthesia during the introductory phases of
he procedure. The images were available to the
nterventional cardiologist on a slave monitor lo-
ated alongside the fluoroscopy screens. The aortic
Table 1. Core TTE Parameters for Study Cohort Recorded at Bas
Characteristic
Baseline Va
(n  50)
Aortic valve area, cm2, mean  SD 0.6 0.2
Mean AVG, mm Hg, mean  SD 46 17
LV ejection fraction, %, median (Q1, Q3) 60 (50, 65)
Mitral regurgitation, median (Q1, Q3) 1 (0, 2)
Aortic regurgitation, median (Q1, Q3) 0 (0, 1)
Severe [4] (%) 0 (0)
Moderate [3] (%) 3 (6)
Mild [2] (%) 21 (42)
None/trivial [0,1] (%) 25 (50)
Signiﬁcant improvement in aortic valve area and mean AVG were noted at pre-d
grading of valvular regurgitation is as follows: 0  none, 1  trivial, 2  mild,
AVG  aortic valve gradient; LV  left ventricular; SD  standard deviation; TTE alve was imaged, and measurements of the aortic
nnulus (Fig. 1B) and left ventricular outflow tract
ere made. Aortic regurgitation was quantitated by
olor Doppler. Careful attention was paid to ana-
omical landmarks such as the distribution of aortic
alve calcification and ectopic calcification of the
asal portion of the anterior mitral leaflet and
nnulus because these were found to be useful in
ptimal placement of the prosthesis. Left and right
entricular systolic function, regional wall motion
bnormalities, and mitral or tricuspid regurgitation
ere noted before and after valve deployment. In
ost cases, the aortic arch was evaluated for the
resence of severe aortic arch atheroma.
For the deployment part of the TEE examina-
ion, the long-axis (130°) transesophageal view was
sed. Long digital loops of 10 to 15 beats were used
o capture the moment of valve deployment. Once
he device was deployed, correct positioning was
erified and any AR classified as valvular or para-
alvular. Balloon re-dilatation of the valve was
erformed if there was more than mild paravalvular
egurgitation. After removal of the deployment
atheter and guidewire, the degree of AR was
eassessed. Limited Doppler estimation of valve
radients via the transgastric window was per-
ormed when image quality permitted and when an
cceptable angle for Doppler interrogation of the
ortic valve was available.
tatistics. Success rate with and without TEE was
ompared using a Fisher exact test. The general
stimating equation was used to assess for any
hanges in the same parameters at 1, 6, and 12
onths. Transesophageal echocardiography and
TE AR severity was compared using the Wil-
oxon signed rank test. The Bland-Altman plot was
sed to compare aortic annular measurements by 2
e and Follow-Up
Implanted Before Discharge 1 Month 6 Mont
 43) (n  42) (n  38) (n  3
 0.2 1.7 0.4* 1.7 0.4 1.6 0
 17 11 5 11 4 11 5
(45, 65) 60 (60, 65)* 65 (60, 65) 64 (56, 6
(1, 2) 1 (0, 2)† 1 (0, 2) 1 (1, 1)
(0, 1) 1 (0, 1)‡ 1 (0, 1) 1 (0, 1)
(0) 0 (0) 0 (0) 0 (0)
(7) 3 (7) 5 (13) 4 (13)
(40) 21 (50) 19 (50) 18 (60)
(51) 18 (43) 12 (32) 8 (27)
rge echocardiogram. These improvements were maintained at 1, 6, and 12 month
moderate, and 4  severe. *p  0.0001; †p  0.01; ‡p  not signiﬁcant.elin
lve hs 12 Months
(n 0) (n  17)
0.6 .5 1.6 0.3
46 14 5
60 5) 60 (55, 65)
2 1 (0, 1)
0 1 (0, 1)
0 0 (0)
3 3 (18)
17 9 (53)
22 5 (29)
ischa s of follow-up. Numerical
3 transthoracic echocardiography.
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18ifferent methods, TEE and TTE. A 2-sided p
alue 0.05 was considered statistically significant.
tatistical analyses were conducted using SPSS
ersion 13.0 (SPSS Inc., Chicago, Illinois).
E S U L T S
ssessment by TTE before device implantation. Base-
ine echocardiographic parameters are shown in
able 1. The column “Valve Implanted” shows
aseline values for all patients in whom a PHV was
mplanted. All patients had severe aortic stenosis
ith a valve area of 0.75 cm2. Median left
entricular ejection fraction was 60% (interquartile
ange 50% to 65%), and median mitral regurgita-
ion was graded mild (interquartile range trivial to
oderate). Mean transthoracic aortic annulus di-
ension was 22  2 mm (range 18 to 26 mm).
EE assessment and guided valve deployment. The
verall immediate success rate was 86% (43 of 50).
alve deployment was successful in 89% of cases
33 of 37) in which TEE was used. The success rate
n patients without procedural TEE was 77% (10 of
3) (not significant, p  0.36). Procedural failure
as due to inability to cross the native aortic valve
The mean difference (TTE-TEE) is -1.36 mm (2 SD  -4.48 to +1.75 mm).
-6
15 20 25 30
Mean + 2SD
Mean - 2SD
MeanT
TE
-T
EE
Average of TTE and TEE
-4
-2
0
2
4
Figure 2. Bland-Altman Plot Illustrating the Difference Between
the Aortic Annular Dimension Determined by TTE and TEE
Important differences may exist between aortic annulus size as
determined by either TTE or TEE. The red circles indicate larger
dimensions by TTE; the black circles indicate agreement; the green
circles indicate larger dimensions by TEE. Annular dimension was
determined by TTE before PHV implantation and TEE dimension at
time of implantation. Abbreviations as in Figures 1 and 4.after valvuloplasty) in 2 cases, inability to pass the pevice through the aortic arch in 1 case, and
alpositioning in 1 case. There were no complica-
ions related specifically to TEE.
evice sizing and annular measurement by TEE.
hirty-three of 50 patients in the series had suc-
essful TEE-guided valve deployment. The differ-
nces between aortic annular dimensions measured
y TEE and TTE are shown in the Bland-Altman
lot in Figure 2. The mean difference in aortic
nnulus dimension was 1.36 mm, with the annulus
imension by TEE yielding larger values than
TE. Within 2 standard deviations of this mean,
he differences between these 2 methods ranged
etween 4.48 and 1.75 mm. A difference of up
o 4 mm between the TTE and the TEE annular
easurements can occur and may lead to a change
n device size.
Preliminary suitability for this procedure has
een based on TTE aortic annulus measurement of
6 mm or less. One of these patients was found to
ave an aortic annulus dimension of 28 mm at
EE, and successful device deployment was under-
aken in this patient with acceptable results.
EE and device deployment. Transesophageal echo-
ardiography was useful as an adjunct to fluoroscopy
n guiding balloon dilatation of the aortic valve and
o assess any subsequent improvement in leaflet
obility. During right ventricular pacing, there
hould be no visible ventricular contraction if cap-
ure is good and pacing rate is appropriate. This can
e verified with TEE before valve deployment.
Transesophageal echocardiography was useful in
ositioning the aortic valve in most (33 of 34)
atients. Lack of utility was due to inadequate
ative valve and PHV visualization. This could
sually be overcome with manipulation of the probe
osition and angulation. Best imaging was in gen-
ral obtained in those patients with less calcified
ortic valves, a situation in which fluoroscopy is
east helpful. Imaging was less useful in patients in
hom acoustic shadowing made clear visualization
f the stented prosthesis on the balloon and its
osition in relation to the aortic annulus difficult.
ood coaxial alignment of the guidewire and sub-
equent direction of the catheter toward the aortic
rifice was important to the success of the proce-
ure. Transesophageal echocardiography was useful
n some instances in ensuring that the steerable
atheter was directed toward the aortic orifice, and
ot directed toward a commissure.
Once the PHV was mounted on the deployment
alloon, careful imaging was required to identify the
recise location of the valve stent in relation to the
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19eployment balloon. Incremental manipulation of
EE probe tip position and angle and selection of
he highest possible frequency are used to optimize
he echocardiographic image. Every attempt was
ade to show both the ventricular and aortic ends
f the stent in one imaging plane. This was not
nvariably possible. For this reason, it was important
or the echocardiographer to be aware of the stent
ength so as to optimize positioning in relation to
he aortic annulus and leaflets. The stent was
dentified as an echogenic rectangular structure seen
n sharp profile to the deployment balloon. In
articular, the identification of the echogenic right
ngle or “shoulder” that corresponded to the ven-
ricular or aortic edge of the stent was a clear
ndication that the stent has been correctly differ-
ntiated from the underlying balloon (Fig. 3A).
ith practice, it was possible to consistently iden-
ify the ventricular and aortic ends of the stent, as
ong as the degree of valve calcification did not
ause excessive shadowing.
The PHV can move up to 2 to 4 mm in the
irection of the ascending aorta with balloon infla-
ion and deployment. The optimal position of the
tented prosthesis (before balloon deployment),
herefore, seems to be when the ventricular end of
he stent is positioned approximately 2 to 4 mm
elow the most ventricular portion of the native
ortic leaflets and annulus. This usually corresponds
o a point just ventricular to the hinge point of the
nterior mitral leaflet. The aortic end of the stent
hould slightly overlie the upper limit of the native
ortic leaflets. The PHV thus lies within the native
ortic leaflets, and during deployment the native
ortic leaflets are compressed between the valve
tent and the wall of the aortic root (Fig. 3B), with
he fabric cuff of the PHV aligned within the aortic
nnulus. After deployment, the aortic end of the
alve stent should be below the level of the coronary
stia. The ventricular end of the valve stent should
ot interfere with anterior mitral leaflet function.
or best results, the valve stent should be closely
pposed to the aortic annulus (Fig. 3C). The valve
s deployed when both echocardiographer and in-
erventionist agree that position is acceptable.
omplications. EARLY DEVICE MIGRATION. Device
igration was noted in 2 patients. In the first
nstance, TEE imaging was not used and the device
as deployed too aortic with respect to the aortic
nnulus. In the second instance, TEE imaging was
sed, however, the presence of a stented mitral valve
rosthesis interfered with the deployment process.
n both instances, the PHVs were subsequentlyFigure 3. TEE-Guided PHV Positioning and Deployment
Good awareness of the echocardiographic appearance of the undeployed PHV
(stent) and its relation to the deployment catheter and balloon is critical to cor-
rect device positioning. (A) Transesophageal echocardiography long-axis view
showing satisfactory stent position before deployment. The undeployed PHV is
identiﬁed as an echogenic rectangular structure, which is seen in contrast to
the larger and less echodense balloon. The ventricular (red arrow) and aortic
(yellow arrow) ends of the stent are indicated in relation to the native aortic
valve (blue arrow). Online Video 1 shows the ideal position for the stented PHV
prior to deployment. (B) Long-axis view at the moment of balloon deployment of
the PHV. The blue arrowheads indicate the balloon and yellow arrows the pros-
thesis. Online Video 2 shows deployment of the PHV by rapid balloon inﬂation. The
ﬁnal appearance of the deployed PHV is seen in panel C. The yellow arrows indi-
cate the stent and the white arrow the prosthetic valve leaﬂet. The fully deployed
PHV is shown in the short-axis view in Online Video 3. Online Video 4 shows
imaging of the deployed prosthesis in the long-axis view. The prosthesis is in
good position and no aortic regurgitation is seen. Abbreviations as in Figure 1.
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20ithdrawn to the aortic arch and redeployed. Both
atients remain well over 1 year later.
VALUATION OF HYPOTENSION. In the presence of
ypotension, TEE provides a rapid early assessment
f changes in global left ventricular systolic function,
itral regurgitation, and the presence or absence of
egional wall motion abnormalities during the critical
eriod immediately before, during, and after valve
eployment. Global left ventricular dysfunction, most
ikely due to global myocardial ischemia, has occasion-
lly been noted immediately before PHV deployment.
his is generally seen as an indication for rapid PHV
Figure 4. Early TEE Assessment of Paravalvular AR After PHV
Deployment
Early assessment of paravalvular AR is an indicator of procedural
success but may also help to determine the need for subsequent
balloon dilatation of the PHV. (A) Transesophageal echocardiogra-
phy showing mild paravalvular regurgitation (red arrow) in the
long-axis view. (B) TEE showing mild paravalvular regurgitation (red
arrow) in the short-axis view. It is the short-axis view that most
reliably distinguishes paravalvular AR from transvalvular AR, espe-
cially if the vena contracta of the paravalvular jet is out of plane in
the long-axis view. Online Video 5 shows a short-axis view of AR
following PHV deployment. Paravalvular AR is seen at the 3 o’clock
position along with a smaller jet of transvalvular AR. AR  aortic
regurgitation; other abbreviations as in Figure 1.eployment. No instances of significant pericardialffusion have been seen; however, the echocardiogra-
her is periodically called on to rule out this diagnosis.
ITRAL REGURGITATION. Transient worsening of
itral regurgitation has been noted in 2 instances
mmediately after valve deployment. In both cases,
his seemed to be related to the use of right
entricular pacing, which is sometimes needed to
reat AV block or bradycardia after valve deploy-
ent. No direct mechanical effect on the mitral
alve of the deployed PHV has been seen.
ARLY TEE ASSESSMENT OF AR. Of the patients
ho underwent successful TEE-guided PHV de-
loyment, 97% (32 of 33) had technically adequate
ssessment of their AR. Some degree of AR was
bserved on TEE in 88% of patients (28 of 32) after
uccessful deployment of the device, and examples
re shown in Figures 4 and 5. Paravalvular AR was
Figure 5. Early TEE Assessment of Transvalvular AR After PHV
Deployment
Immediately after PHV deployment, paravalvular AR must be
distinguished from transvalvular AR. The short-axis views may be
especially useful in this instance. Transesophageal echocardiog-
raphy showing mild valvular regurgitation (red arrow) in the
long-axis (A) and short-axis (B) views. Abbreviations as in Fig-
ures 1 and 4.
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21bserved on TEE in 84% of cases (27 of 32). One
atient had isolated valvular regurgitation.
Early grading of AR severity by TEE was useful in
uiding subsequent management. In 13 patients, it
as judged that significant paravalvular AR was
resent immediately after valve deployment, and ad-
itional balloon dilatation of the PHV was performed
n 12 of these. One patient with moderate paravalvular
R early in the series did not undergo additional
alloon dilatation. Of the patients who underwent
dditional balloon dilatation, 7 of 13 had improve-
ent of paravalvular AR by at least 1 grade.
The results for overall TEE assessment of AR, at
he end of the procedure, are presented in Table 2.
ost patients (26 of 32, 81%) had mild or less AR
t the conclusion of the case. No instances of severe
R were seen. The most common site of regurgi-
ation is in relation to the posterior aspect of the
tent; however, paravalvular jets may occur in any
art of the circumference of the annulus.
In 1 instance, residual native aortic valve leaflet
issue was seen to prolapse into the PHV and
nterfere with leaflet motion, causing mild valvular
R, a complication that may have resulted from
nsufficient containment of residual native aortic
issue by the PHV, allowing redundant valve leaflet
o interfere with prosthetic leaflet coaptation.
HROMBUS. Mobile echogenic material has been
oted in relation to the deployed PHV on 2 occasions.
lthough we have assumed this to be thrombus, it
ould be difficult to differentiate this appearance
rom that of fragmented aortic leaflet material that
ad been inadequately contained by the PHV.
NUSUAL COMPLICATIONS. Exuberant aortic leaf-
et calcium was displaced into the ostium of the left
ain coronary artery in 1 instance. Death from
resumed myocardial ischemia occurred a few days
fter the procedure. This situation was not recog-
ized at TEE but was visualized retrospectively on
uoroscopy and confirmed at autopsy. In another
ase there was fatal rupture of the descending
horacic aorta by the deployment assembly. In that
nstance, TEE was able to visualize the periaortic
ematoma (Fig. 6).
TE POST-DEPLOYMENT. Pre-discharge TTE was
erformed on 42 of 43 patients in whom the PHV
ad been successfully deployed. One patient died
fter successful deployment but before TTE could
e performed. The PHV was well seated in all
atients, and there were no instances of delayed
evice migration. There were significant improve-
ents in aortic valve area and mean pressure gra-ient after successful valve deployment (Table 1).
n example of a typical result is shown in Figures
A and 7B.
Post-implantation TTE has shown favorable re-
ults with regard to AR in the majority of patients
o date. Some degree of AR was present in 93% of
atients (39 of 42) on the pre-discharge TTE but in
ost instances was trivial or mild. The results for
TE assessment of AR are presented in Table 1.
Overall AR grade was unchanged between the
aseline pre-procedure TTE and the post-
mplantation TTE assessment (p  0.20). In all 3
ases in which AR was moderate before valve
mplantation, AR severity decreased to trivial or
ild.
R GRADE BY PROCEDURAL TEE AND EARLY
OLLOW-UP TTE. A comparison of AR grade by
rocedural TEE and early follow-up TTE of the 31
atients with successful TEE-guided implantation
Figure 6. Periaortic Hematoma After Attempted PHV
Deployment
Periaortic hematoma as a result of rupture of the lower
descending thoracic aorta is an unusual complication of PHV
deployment. In this instance the patient became hypotensive as
the PHV assembly was being advanced through the abdominal
and lower thoracic aorta. Contrast injection showed extravasa-
tion of dye, after which TEE was used to identify peri-aortic
Table 2. TEE Assessment of Aortic Regurgitation Immediately Afte
Grade of Aortic Regurgitation by TEE
(n  32)* Trivial Mild
Mixed aortic regurgitation (overall grade)
(n  14)
5 6
Isolated paravalvular regurgitation (n  13) 2 8
Isolated valvular regurgitation (n  1) 1 0
No aortic regurgitation (n  4) — —
Most patients had mild or less aortic regurgitation, and no instances of severe
seen. *Aortic regurgitation not assessed in 1 patient.
PHV  percutaneous heart valve; TEE  transesophageal echocardiography.r PHV Implantation
Moderate Severe
3 0
3 0
0 0
— —
aortic regurgitation werehematoma. Abbreviations as in Figure 1.
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22s presented in Figures 8A and 8B (1 successful
EE-guided case was excluded because of death
efore discharge TTE). Less valvular AR was ob-
erved at early follow-up TTE assessment than was
resent at post-implantation TEE (p  0.02).
I S C U S S I O N
ortic annulus measurement and device sizing.
ransesophageal echocardiography has assumed an
ncreasingly important role in the successful sizing
nd deployment of the PHV, and hence is critical to
inimizing the potential for device migration, un-
cceptable AR, or ineffective treatment of the aortic
tenosis. Correct sizing of the valve is critical to
tability post-deployment and to minimizing the
ensional Appearances and Doppler Gradients After PHV Implanta
s the potential to give excellent early morphologic and hemodynam
after (B) implantation of a PHV. Successful PHV implantation also lea
adients in the same patient are shown before (C) and after (D) PHV iotential for paravalvular AR. The larger valve cssembly may not be able to be advanced in the
resence of marginal vascular access or may be
nable to cross the aortic valve in the presence
f a very small annular dimension. By comparison,
ignificant undersizing of the PHV may result
n device migration or in unacceptable paravalvu-
ar AR.
Measurement of the aortic annulus by TTE is an
mportant consideration in initial patient selection.
e deemed some patients unsuitable on the basis
hat their annular size was either too large or too
mall to accommodate a valve presently available;
owever, the proportion of the patient population
ith severe aortic stenosis that would be ruled out
or PHV is likely to be small. After review by the
sults. Transesophageal echocardiography long-axis views are
a marked early reduction in transaortic pressure gradient.
antation. Abbreviations as in Figure 1.Figure 7. Early 2-Dim tion
A PHV implantation ha ic re
shown before (A) and ds toore group, which included an interventional cardi-
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23logist and 2 echocardiographers, fewer than 5 cases
ere deemed unsuitable for PHV implantation by
chocardiographic criteria during the study period.
his being said, we have empirically chosen the cut
oints for annulus dimension that we believe are
nfavorable, so the true limits for the present
echnology remain undefined.
The disparity noted between the TTE and TEE
easurements of aortic annulus size is of interest
nd may reflect acoustic blooming possibly exacer-
ated by use of harmonic imaging with TTE.
lthough preliminary suitability for implantation
as based on TTE annular dimension, the PHV
as sized according to the TEE annulus dimension,
aking into account patients with borderline vascu-
ar access that may only have permitted the use of a
maller device. In general, the 23-mm prosthesis
as been considered appropriate for an aortic annu-
us size of 18 to 22 mm and the 26-mm device for
n aortic annulus size of 21 to 26 mm, with the
arger prosthesis being used where possible. Because
he PHV is sized according to annulus dimension
easured by TEE, the impact of any mismatch in
he 2 measurements is likely to be minimal. No
rocedure has been cancelled on the basis of an
versize TEE annular dimension, and no devices
ecame unstable or were displaced because of excess
nnular dimension. If the TTE measurement only
ad been used to size the PHV, we believe that the
EE measurement may have modified the TTE
stimate sufficiently to lead to a change in PHV size
n 5 patients. For patients with borderline vascular
ccess, accurate annular sizing by TEE has given
he operator confidence to use the smaller (23 mm)
HV when annulus has been measured in the 22-
o 23-mm range by TTE.
Echocardiography will perform an even more
mportant function in PHV sizing when manufac-
urers deliver a wider range of more specialized
evices of varying dimensions.
EE and procedural outcomes. Although TEE is
ow seen as an integral adjunct to PHV deploy-
ent, limitations inherent in the design of our
tudy mean that we are unable to determine con-
lusively that TEE has improved procedural out-
omes. Although encouraging, the nonsignificant
rend toward improved outcomes in the TEE co-
ort might also be influenced by subtle improve-
ents in deployment technique likely to have arisen
hrough experience.
R. Paravalvular AR, initially anticipated to be a
ajor limitation, does not now seem likely to limithe application of this technique AR is most likely uo occur if the fabric cuff is not approximated to the
lane of the annulus. Even with correct device
ositioning, AR may occur at sites adjacent to areas
f leaflet compression where accumulated nodular
alcium and leaflet tissue mean that a snug seal
annot be obtained. Aortic regurgitation tends to be
raded higher by TEE than by early post-
rocedural TTE. This may be due to interpretative
ifferences between the 2 imaging techniques, res-
itution of leaflet shape after initial balloon defor-
ation, or thrombosis in the zone between the
rushed aortic valve leaflet and stent.
The difficulties in accurately assessing paravalvular
R by standard echocardiographic methods remain
n important limitation of this study. It is important
o note that published guidelines relate to native valve
egurgitation (5), and for a variety of reasons the
raditional echocardiographic approaches to quantitat-
ng paravalvular AR may be limited. We have ob-
erved in many instances that the vena contracta of the
aravalvular AR jet is either crescentic in shape or
onsists of multiple small jets. Therefore it seems
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Figure 8. A Comparison of Valvular and Paravalvular AR as Gra
After Successful TEE-Guided PHV Implantation (n  31)
The grade of paravalvular and valvular AR tended to be higher in t
ment, although this was only signiﬁcant for valvular AR (p  0.02).
paravalvular AR assessed by early TEE and TTE. (B) A comparison of
by TEE and TTE. Less valvular AR was observed at post-implantation
Transesophageal echocardiography AR grade is the ﬁnal grade at th
dure. Transthoracic echocardiography refers to the grade of AR on
TTE. Abbreviations as in Figures 1 and 4.re
TEE
TTE
p=0.51
re
TEE
TTE
p=0.02
ded by TEE and TTE
he early TEE assess-
(A) A comparison of
valvular AR assessed
TTE assessment.
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24imension and vena contracta width will accurately
ssess the AR in that they are constrained by inherent
eometrical assumptions. Similarly convergence
ethods for quantitating AR severity assume a circu-
ar regurgitant orifice. An ideal solution would be to
olumetrically determine regurgitant fraction and re-
urgitant volume; however, this approach is limited by
he technically difficult nature of many of our studies
nd the presence of significant mitral regurgitation in
thers. Pressure half-time determination of AR sever-
ty is limited in that it reflects aortic and ventricular
ompliance as well as orifice area, and like the other
echniques, is unvalidated in this setting.
The incidence of minor degrees of paravalvular
R after conventional surgical aortic valve replace-
ent is variable but may be as high as 48% (7,8).
he clinical significance of small paravalvular AR
ets is likely to be benign and the regurgitation
onprogressive in the majority of patients (8).
ased on the surgical experience, therefore, it seems
nlikely that the minor degrees of early AR that we3006–8. Prevalence and clininto clinically important long-term effects, assum-
ng device stability is maintained.
eft ventricular ejection fraction and MR. Early im-
rovements in left ventricular ejection fraction and
itral regurgitation following PHV implantation
Table 1) have been reported and are more exten-
ively discussed elsewhere (9).
O N C L U S I O N S
he feasibility and relative safety of PHV implan-
ation has now been demonstrated, as having im-
ortant and potentially clinically significant im-
rovements in aortic valve hemodynamics. As the
echnical aspects and clinical understanding of this
echnique continue to evolve, echocardiography will
ave a crucial role in the future development of the
ercutaneous treatment of aortic valve disease.
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